Skip to main content
BloomShieldShielded by care. Empowered to bloom.
Research & Innovation

Africa · Proposed multinational research programme

ACCEPT SIMS™
African Research Partnerships

A proposed collaborative research and implementation programme exploring how digital screening intelligence can strengthen referral navigation and continuity of care in Nigeria, Zimbabwe and Kenya.

  • Nigeria flag

    Nigeria

    Community implementation and clinical research

  • Zimbabwe flag

    Zimbabwe

    Research expansion and evaluation

  • Kenya flag

    Kenya

    Health-system validation and impact

The institutional relationships described here support research collaboration. The ACCEPT SIMS™ field-validation programme is proposed: participating sites, responsibilities, protocols, approvals and resources remain to be agreed. No award of funding is implied.

Programme overview and research ambition

BloomShield’s ambition is to develop a locally led, multinational research programme that connects cervical screening information with referral navigation and continuity of care. ACCEPT SIMS™ could provide a shared research architecture while allowing each setting to retain its own priorities, clinical pathways and governance.

The proposed programme would explore feasibility and implementation across Nigeria, Zimbabwe and Kenya. Its purpose is to generate evidence about what works, for whom and under what conditions, before any wider adoption is considered.

The screening-to-follow-up problem

A recorded screening result does not establish that a person received the result, reached a referral service or completed follow-up. The research ambition is to make these transitions visible and understand where people need support.

  1. Screening and result recording
  2. Result communication and referral
  3. Navigation to appropriate services
  4. Follow-up and documented pathway resolution

Proposed research would examine barriers such as transport, cost, communication and service availability alongside the experience of participants and care teams. Definitions of completion and resolution would be agreed with local clinical leadership.

ACCEPT SIMS™ technology and synthetic-data limitations

The existing ACCEPT SIMS™ demonstrator explores a longitudinal screening registry, navigation information and future AI evaluation. It currently uses entirely synthetic participant records and is for research discussion and co-design.

Synthetic data can illustrate workflows and information structures. It cannot establish clinical accuracy, patient benefit, real-world usability, safety, fairness or effectiveness. The demonstrator is not a deployed clinical system, a validated AI system or a replacement for clinical judgement.

Any study using real participant data would need a separately agreed protocol, lawful data arrangements, appropriate consent, security controls and applicable ethics and regulatory approvals. Any AI evaluation would require its own defined model, reference standard and oversight.

Institutional research relationships

The collaborative research framework brings together technology development, academic research, clinical evaluation and healthcare implementation capabilities. The relationships below inform programme development; participation in proposed ACCEPT SIMS™ field validation would require further institutional and local agreements.

BloomShield CIC

Technology development and research coordination

BOLSBOY International Limited

Nigerian healthcare operations and proposed implementation

Community and implementation relationships

Optimal Cancer Care Foundation and Lifecrown Foundation are also included in the wider partnership landscape. Their involvement in any ACCEPT SIMS™ study, including responsibilities and site-level arrangements, would be defined through further discussion and agreement.

Institutional roles describe the research relationships and proposed areas of contribution. They do not indicate an approved field trial, confirmed deployment or awarded funding.

Nigeria, Zimbabwe and Kenya: proposed research workstreams

These workstreams are proposals for co-design. Final scope, sites and leadership would be agreed with the relevant institutions and local teams.

Nigeria

Community implementation and clinical research

Co-design community recruitment, screening-to-referral workflows and navigation research with local clinical, academic and implementation teams. Explore how practical barriers and follow-up can be recorded in routine settings.

BOLSBOY International Limited — Digital Health Innovation

BOLSBOY’s own corporate digital-health partnership page showcases its collaboration with BloomShield CIC and ACCEPT SIMS™.

Zimbabwe

Research expansion and evaluation

Explore adaptation to local clinical research settings, evaluate data completeness and workflow feasibility, and develop locally relevant implementation and evaluation questions.

Kenya

Health-system validation and impact

Explore alignment with cancer-control priorities, referral systems and programme evaluation. Assess what evidence would be needed to understand feasibility, equity and potential health-system impact.

Field-validation methodology and expected research questions

A proposed staged, mixed-methods approach would begin with local pathway mapping and co-design. Feasibility work would precede any larger evaluation. Sample sizes, study duration, comparison methods and analysis plans remain to be specified in an agreed protocol.

  1. Map and co-design: establish local referral pathways, participant priorities, data definitions and success measures.
  2. Assess readiness: agree governance, approvals, staff training, technical requirements and data-quality checks before real-data collection.
  3. Study feasibility: examine workflow fit, usability, data completeness, staff workload and participant experience in agreed settings.
  4. Evaluate and learn: combine pathway measures with interviews and implementation evidence, reporting uncertainty and differences between settings.

Questions the research could examine

  • Can screening, communication, referrals and follow-up be recorded consistently across settings?
  • Where do pathways stall, and which locally designed navigation approaches are feasible?
  • What are the completeness, timeliness and reliability of the resulting data?
  • How do participants and staff experience the workflows, including language and digital-access barriers?
  • What differences emerge between sites and groups, and what costs and capacity would wider use require?

Potential measures include referral completion, time to follow-up, unresolved pathways, acceptability and implementation cost. These are proposed research outcomes, not demonstrated benefits. If AI is included in a future protocol, model performance and clinician agreement would be evaluated separately from pathway outcomes.

Local leadership, capacity building and responsible innovation

Country teams and communities should help define the questions, implementation choices and interpretation of findings. Proposed capacity building would include shared training in pathway documentation, data quality, evaluation and responsible digital-health research.

  • Agree local clinical accountability, participant safeguarding and escalation routes.
  • Co-design consent, accessible communication and participant involvement.
  • Define data stewardship, access permissions, retention and any cross-border transfers before data collection.
  • Agree equitable authorship, knowledge exchange and dissemination with participating teams.
  • Assess bias, unintended effects and resource demands; retain human oversight of care decisions.

The aim is useful, locally meaningful evidence that can inform decisions about adaptation and scale. Wider implementation would depend on the findings and on further agreements and approvals.

Partnership enquiries

We welcome discussions with academic, clinical, cancer-control, community and implementation organisations interested in co-designing this research. Tell us about your setting, proposed contribution and the pathway questions that matter locally.

Partnership Requests

The contact form will open with the African Research Partnerships enquiry category selected.